Inventor
COVEY DOUGLAS
US12 patents
⚠️ This page may combine multiple inventors who share the name “COVEY DOUGLAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV WASHINGTON
9 patentsUS9630986B2Apr 25, 2017
Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
UNIV WASHINGTON49 citations97
US9676812B2Jun 13, 2017
Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
UNIV WASHINGTON15 citations92
US10342809B2Jul 9, 2019
Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
UNIV WASHINGTON11 citations83
US10202413B2Feb 12, 2019
Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for GABA type-A receptors
UNIV WASHINGTON2 citations71
US10160783B2Dec 25, 2018
Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
UNIV WASHINGTON1 citations51
US9512170B2Dec 6, 2016
Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
UNIV WASHINGTON0 citations51
US10160738B2Dec 25, 2018
Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors
UNIV WASHINGTON0 citations50
US9562026B2Feb 7, 2017
Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors
UNIV WASHINGTON0 citations50
US9365502B2Jun 14, 2016
Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors
UNIV WASHINGTON0 citations40
COVEY DOUGLAS
2 patentsUS11497754B2Nov 15, 2022
Neurosteroids and enantiomers thereof for the prevention and treatment of neurodegenerative conditions
COVEY DOUGLAS2 citations64
US9388210B2Jul 12, 2016
Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
COVEY DOUGLAS0 citations28